Balyasny Asset Management LLC Amylyx Pharmaceuticals, Inc. Transaction History
Balyasny Asset Management LLC
- $54.9 Billion
- Q2 2024
A detailed history of Balyasny Asset Management LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 22,887 shares of AMLX stock, worth $70,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,887Holding current value
$70,491% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
44.6MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$13 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.34MShares$10.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$8.22 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$8.04 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.9MShares$5.86 Million1.57% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $180M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...